Inventor · disambiguated record
Justus Adamson
Also filed as: ADAMSON JUSTUS
13 granted patents·4 pending applications·30 citations·filing 2015–2024
88Inventor score
Top patents by PatentIndex Score
17 records- 0189US10596387B2Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2015·Granted Mar 24, 2020·13 cites·108 claims
- 0288US11786595B2Methods for radiotherapy to trigger light activation drugsIMMUNOLIGHT LLC·Filed 2021·Granted Oct 17, 2023·1 cites·52 claims
- 0387US11207409B2X-RAY psoralen activated cancer therapy (X-PACT) with associated treatmentsIMMUNOLIGHT LLC·Filed 2018·Granted Dec 28, 2021·3 cites·32 claims
- 0486US11376445B1Systems and methods for single isocenter radiotherapy of multiple targetsUNIV DUKE·Filed 2020·Granted Jul 5, 2022·3 cites·18 claims
- 0584US11865359B2Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2019·Granted Jan 9, 2024·1 cites·97 claims
- 0681US11305131B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2019·Granted Apr 19, 2022·1 cites·37 claims
- 0780US10940329B2Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for useIMMUNOLIGHT LLC·Filed 2017·Granted Mar 9, 2021·1 cites·33 claims
- 0877US2024342287A1Phosphor-containing drug activator kitIMMUNOLIGHT LLC·Filed 2024·Application pending·0 cites
- 0976US11260129B2Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for useIMMUNOLIGHT LLC·Filed 2017·Granted Mar 1, 2022·2 cites·91 claims
- 1074US10441810B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2017·Granted Oct 15, 2019·3 cites·41 claims
- 1174US2024042233A1Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2023·Application pending·0 cites
- 1271US12226483B2Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for useIMMUNOLIGHT LLC·Filed 2021·Granted Feb 18, 2025·0 cites·19 claims
- 1371US11135294B2Methods for radiotherapy to trigger light activation drugsIMMUNOLIGHT LLC·Filed 2016·Granted Oct 5, 2021·1 cites·100 claims
- 1467US11992697B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2022·Granted May 28, 2024·0 cites·35 claims
- 1565US11577092B2Phosphor-containing drug activator activatable by a monte carlo derived X-ray exposure, system containing the activator, and methods for useIMMUNOLIGHT LLC·Filed 2017·Granted Feb 14, 2023·1 cites·9 claims
- 1659US2022161062A1Systems and methods for quality assurance in radiation therapy with collimator trajectory dataUNIV DUKE·Filed 2021·Application pending·0 cites
- 1742US2021236855A1Systems and methods of quality assurance for radiotherapyUNIV DUKE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justus Adamson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →